Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M7LV
|
|||
| Former ID |
DNC008882
|
|||
| Drug Name |
LYSERGIC ACID DIETHYLAMIDE
|
|||
| Synonyms |
Lysergide; D-Lysergic acid diethylamide; Delysid; D-Lsd; N,N-Diethyllysergamide; Lysergamid; 50-37-3; Lysergsaeurediaethylamid; Cubes; Pearly gates; Heavenly Blue; Lysergaure diethylamid; Royal blue; N,N-Diethyl-D-lysergamide; LSD (alkaloid); Lysergidum; Wedding bells; Lysergsauerediaethylamid; Lysergic acid diethylamide-25; LSD 25; Lysergidum [INN-Latin]; LSD-25; Lisergide [DCIT]; Lysergamide, N,N-diethyl-; Ubergluben; Clearlight; Sunshine; Cupcakes; Greenies; Barrels; Yellows; Trippers; Microdots; Spoonies
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Addictive disorder [ICD-11: 6C50-6C5Z] | Withdrawn from market | [1], [2] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H25N3O
|
|||
| Canonical SMILES |
CCN(CC)C(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C
|
|||
| InChI |
1S/C20H25N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3/t14-,18-/m1/s1
|
|||
| InChIKey |
VAYOSLLFUXYJDT-RDTXWAMCSA-N
|
|||
| CAS Number |
CAS 50-37-3
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
9745, 841062, 7979834, 8153537, 15470164, 15976361, 24896390, 29224797, 46506397, 46530543, 47216998, 47589197, 47810991, 48185195, 48416190, 49689414, 49965400, 50113078, 57322936, 76084429, 103164236, 104098839, 104310181, 124893452, 127253497, 127253498, 127253499, 127253500, 127253501, 127253502, 127253503, 127253504, 127253505, 127253506, 127253507, 127253508, 127253509, 127253510, 127253511, 127253512, 127253513, 127253514, 127253515, 127253516, 127253517, 127253518, 127253519, 127253520, 127253521, 127253522
|
|||
| ChEBI ID |
CHEBI:6605
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 17). | |||
| REF 2 | Psychopathology and psychophysiology of minimal LSD-25 dosage; a preliminary dosage-response spectrum. AMA Arch Neurol Psychiatry. 1958 Feb;79(2):208-10. | |||
| REF 3 | Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanes. J Med Chem. 1995 Mar 17;38(6):958-66. | |||
| REF 4 | C-(4,5,6-trimethoxyindan-1-yl)methanamine: a mescaline analogue designed using a homology model of the 5-HT2A receptor. J Med Chem. 2006 Jul 13;49(14):4269-74. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.